The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity.
D000293:Adolescent; D000328:Adult; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005260:Female; D012739:Gonadal Steroid Hormones / Q000378:metabolism*; D006801:Humans; D008234:Lynestrenol / Q000494:pharmacology; D008297:Male; D008525:Medroxyprogesterone / Q000494:pharmacology; D008535:Megestrol / Q000494:pharmacology; D008593:Menopause; D008875:Middle Aged; D009644:Norgestrel / Q000494:pharmacology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D045167:Progesterone Congeners / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D012712:Serum Globulins / Q000378:metabolism*
D004338:Drug Combinations; D012739:Gonadal Steroid Hormones; D045167:Progesterone Congeners; D012712:Serum Globulins; D009644:Norgestrel; D004997:Ethinyl Estradiol; D008535:Megestrol; D008525:Medroxyprogesterone; D008234:Lynestrenol